Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
作者信息
Cowan M J, Martin D W, Wara D W, Ammann A J
出版信息
Adv Exp Med Biol. 1984;165 Pt A:39-45. doi: 10.1007/978-1-4684-4553-4_8.
PMID:6609530
Abstract
摘要
相似文献
1
Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.腺苷脱氨酶缺乏症患者的静脉注射脱氧胞苷治疗。
Adv Exp Med Biol. 1984;165 Pt A:39-45. doi: 10.1007/978-1-4684-4553-4_8.
2
Amelioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency.腺苷脱氨酶缺乏症“酶替代”治疗后神经功能异常的改善
N Engl J Med. 1980 Aug 14;303(7):377-80. doi: 10.1056/NEJM198008143030706.
3
Adenosine deaminase deficiency and severe combined immunodeficiency disease.腺苷脱氨酶缺乏症与重症联合免疫缺陷病
Adv Enzymol Relat Areas Mol Biol. 1980;51:167-210. doi: 10.1002/9780470122969.ch4.
4
Immune cell function and recycling of purines.免疫细胞功能与嘌呤的循环利用。
N Engl J Med. 1976 Dec 9;295(24):1375-6. doi: 10.1056/NEJM197612092952409.
5
New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.腺苷脱氨酶（ADA）缺乏症诊断与治疗的新视角。
Adv Exp Med Biol. 1984;165 Pt A:33-8. doi: 10.1007/978-1-4684-4553-4_7.
6
Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.嘌呤代谢缺陷相关免疫缺陷病发病机制的研究进展
Monogr Hum Genet. 1978;10:88-91. doi: 10.1159/000401572.
7
Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.双嘧达莫和静脉注射脱氧胞苷治疗腺苷脱氨酶缺乏症患者。
Birth Defects Orig Artic Ser. 1983;19(3):117-20.
8
Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏患者的治疗。
Clin Biochem. 1983 Feb;16(1):43-7. doi: 10.1016/s0009-9120(83)94381-3.
9
Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.酶替代疗法后嘌呤核苷磷酸化酶缺乏症中的红细胞代谢
Monogr Hum Genet. 1978;10:104-7. doi: 10.1159/000401576.
10
[Immunological failure caused by adenosine deaminase deficiency].[腺苷脱氨酶缺乏导致的免疫功能衰竭]
Acta Haematol Pol. 1979 Jul-Sep;10(3):205-10.
引用本文的文献
1
SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.SLGT2 抑制剂可挽救 G6PC3 缺乏症中的骨髓造血。
J Clin Immunol. 2022 Nov;42(8):1653-1659. doi: 10.1007/s10875-022-01323-4. Epub 2022 Jul 15.
Zotero 插件